Threonic acid, an ascorbic acid metabolite, synergizes with intermittent fasting to ameliorate obesity.

Intermittent fasting (IF) is a safe and sustainable approach for obesity treatment, yet its weight loss efficacy is relatively modest compared with that of pharmacologic anti-obesity therapies. The synergistic benefits of pairing IF with administrati…

Preview only. Read the full abstract at the source